Cargando…

Anti-BIP antibodies in rheumatoid arthritis

Detalles Bibliográficos
Autores principales:	Panayi, GS, Bodman-Smith, M, Corrigall, V
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2003
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833586/ http://dx.doi.org/10.1186/ar649

Ejemplares similares

The human chaperone BiP stimulates interleukin(IL)-10 producing CD8 T cells: implications for rheumatoid arthritis
por: Bodman-Smith, MD, et al.
Publicado: (2002)

BiP may have an immunoregulatory function mediated through IL-10 production
por: Corrigall, VM, et al.
Publicado: (2002)

The p78 Putative Rheumatoid Arthritis T Cell Autoantigen
por: Panayi, GS, et al.
Publicado: (2000)

The molecular chaperone BiP (GRP 78) inhibits the differentiation of normal human monocytes into immature dendritic cells
por: Vittecoq, O, et al.
Publicado: (2003)

BiP induces IL-4-dependent regulatory cells
por: Brownlie, R, et al.
Publicado: (2005)

The stress protein BiP is a major autoantigen in rheumatoid arthritis
por: Neuhaus-Steinmetz, U, et al.
Publicado: (2001)

Protein microarray characterization of autoantibody responses in rheumatoid arthritis and systemic lupus erythematosus
por: Robinson, W, et al.
Publicado: (2002)

Anti-Ro/SSA antibodies in rheumatoid arthritis (RA)
por: Franceschini, F, et al.
Publicado: (2003)

A New-Age for Biologic Therapies: Long-Term Drug-Free Therapy with BiP?
por: Shields, Adrian M., et al.
Publicado: (2012)

Immunodiagnosis and therapeutic immunosuppression in rheumatoid arthritis with ior t1 (anti-CD6) monoclonal antibody
por: Montero, E, et al.
Publicado: (2002)

Induction of ANA, anti-dsDNA and anti-nucleosome antibodies following infliximab treatment in rheumatoid arthritis and spondyloarthropathy patients
por: de Rycke, LEB, et al.
Publicado: (2002)

The significance of antibodies to cyclic citrullinated peptide, antikeratin antibodies, anti-perinuclear factor, rheumatoid factor isotypes and HLA shared epitope in prediction of erosive disease in early rheumatoid arthritis patients
por: Vencovsky, J, et al.
Publicado: (2001)

Obstacles to Anti-CD4 Therapy in Rheumatoid Arthritis
por: Kalden, Joachim R, et al.
Publicado: (2000)

Influence of anti-TNF therapy on monocyte gene expression in rheumatoid arthritis
por: Hernandez, M, et al.
Publicado: (2003)

Antineutrophil cytoplasmic antibodies in synovial fluid from patients with early rheumatoid arthritis
por: Puszczewicz, M, et al.
Publicado: (2003)

Clinical sensitivity of antibodies against cyclic citrulinated peptide in patients with rheumatoid arthritis
por: Bozic, B, et al.
Publicado: (2001)

Anti-skin anti-intercellular antibodies in juvenile idiopathic arthritis
por: Hromadnikova, I, et al.
Publicado: (2001)

Anti-keratin antibodies in juvenile idiopathic arthritis
por: Hromadnikova, I, et al.
Publicado: (2001)

Binding immunoglobulin protein resolves rheumatoid synovitis: a xenogeneic study using rheumatoid arthritis synovial membrane transplants in SCID mice
por: Yoshida, Kaoru, et al.
Publicado: (2011)

Genetics of Rheumatoid Arthritis
por: Nepom, Gerald T
Publicado: (2000)

Chemokines in Rheumatoid Arthritis
por: Koch, Alisa
Publicado: (2000)

Investigation of the epitopes of human profilaggrin derived peptide targeted by antibodies of patient with rheumatoid arthritis
por: Brozik, M, et al.
Publicado: (2001)

Chaperonins and the regulation of immunity
por: Panayi, GS, et al.
Publicado: (2005)

Dendritic Cells: What Is Their True Role in Rheumatoid Arthritis?
por: Thomas, R, et al.
Publicado: (2000)

Ability of second-generation anti-cyclic citrullinated peptide (CCP) to predict rheumatoid arthritis in patients with early arthritis
por: Saraux, A, et al.
Publicado: (2003)

Digital vasculitis in a patient with rheumatoid arthritis: good response on anti-TNF blockade
por: van den Hoogen, F, et al.
Publicado: (2001)

Detection of rheumatoid arthritis-specific anti-filaggrin antibodies by line immunoassay shows complementarity to RF and corresponds to the AFA-blot using natural antigen
por: Union, A, et al.
Publicado: (2001)

The effect of infliximab on rheumatoid factor and anti-citrullinated cyclic peptide antibodies
por: van Damme, N, et al.
Publicado: (2002)

Autoreactivity patterns in rheumatoid arthritis
por: Behrens, S, et al.
Publicado: (2001)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis
por: Shoda, Hirofumi, et al.
Publicado: (2011)

Effects of anti-rheumatic treatments on expression of microsomal prostaglandin E synthase-1 in rheumatoid arthritis synovium
por: Korotkova, M, et al.
Publicado: (2004)

Anti-TNF-α antibody Infliximab and glucocorticoids reduce serum vascular endothelial growth factor (VEGF) levels in patients with rheumatoid arthritis: a pilot study
por: Strunk, J, et al.
Publicado: (2004)

Fibrinogen-specific T cells in rheumatoid arthritis
por: Vossenaar, E, et al.
Publicado: (2003)

Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2004)

Dendritic cell subsets in rheumatoid arthritis
por: Summers, K, et al.
Publicado: (2001)

Histopathology of Bone Erosions in Rheumatoid Arthritis
por: Gravallese, Ellen, et al.
Publicado: (2000)

Synovial Histopathology in Early Rheumatoid Arthritis
por: Hirohata, Shunsei, et al.
Publicado: (2000)

Activation of Synovial Fibroblasts in Rheumatoid Arthritis
por: Gay, Steffen, et al.
Publicado: (2000)

Binding Immunoglobulin Protein (BIP) Inhibits TNF‐α–Induced Osteoclast Differentiation and Systemic Bone Loss in an Erosive Arthritis Model
por: Zaiss, Mario M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kpnl95nk3gjgske02qldbbs7nl